Condition
Fecal Microbiota Transplant
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
P 2 (1)
Trial Status
Completed2
Terminated1
Withdrawn1
Enrolling By Invitation1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05826418Not ApplicableCompleted
Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation
NCT06262451Enrolling By InvitationPrimary
Fecal Microbiota Transplant National Registry
NCT04139577Phase 1Completed
FMT In High-Risk Acute GVHD After ALLO HCT
NCT04968951Early Phase 1Terminated
Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)
NCT03829878Phase 2Withdrawn
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)
Showing all 5 trials